Skip to main content

Find Clinical Trials

Home
Conditions
Mesothelioma

Clinical trial condition

Mesothelioma

Explore clinical trials studying Mesothelioma. Study availability and eligibility vary by location and protocol.

184 public trials 34 recruiting studies

Refine in advanced search Browse all conditions

Mesothelioma trial results

Recruiting

SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma

NCT05568680

Conditions: Adenoma, Adnexal Diseases, Cholangiocarcinoma Recurrent, +26 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

University of Kansas Cancer Center Westwood, Kansas, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Evaluation of Skin Tests in Biotherapy Allergies

NCT06971848

Conditions: AL Amyloidosis, Adenocarcinoma, Adenoma, +75 more
Locations: CHU Angers Angers, France

View Trial Details

Recruiting

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma

NCT05765084

Conditions: Adenoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, +26 more
Locations: Antwerp University Hospital Edegem, Antwerp, Belgium

AZ Maria Middelares Ghent, Belgium

VITAZ Sint-Niklaas, Belgium

View Trial Details

Recruiting

Multidimensional Omics Analysis in Malignant Pleural Mesothelioma

NCT07561190

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Azienda Ospedaliera Universitaria Policlinico Rodolico San Marco di Catania Catania, Italy

Azienda Ospedaliera Universitaria Luigi Vanvitelli, Napoli Naples, Italy

Azienda USL IRCCS di Reggio Emilia Reggio Emilia, Italy

Fondazione Policlinico Universitario Agostino Gemelli IRCCS Roma, Italy

View Trial Details

Recruiting

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

NCT06362369

Conditions: ALK Genomic Tumor Aberrations, Adenocarcinoma, Adenoma, +69 more
Locations: University of Colorado Cancer Center Aurora, Colorado, United States

Florida Cancer Specialists Lake Mary, Florida, United States

Dartmouth Hitchcock Lebanon, New Hampshire, United States

Brown University Health Cancer Institute Providence, Rhode Island, United States

View Trial Details

Recruiting

Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors

NCT07443020

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +17 more
Locations: AHN West Penn Hospital Pittsburgh, Pennsylvania, United States

View Trial Details

Recruiting

Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma

NCT05655078

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: East Sussex Healthcare NHS Trust - Eastbourne Hospital Eastbourne, East Sussex, United Kingdom

East Sussex Healthcare NHS Trust - Conquest Hospital Saint Leonards-on-Sea, East Sussex, United Kingdom

Royal Berkshire Hospital Reading, England, United Kingdom

Southend University Hospital Southend, Essex, United Kingdom

View all 25 locations

View Trial Details

Recruiting

INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP)

NCT07403630

Conditions: Acute Leukemia, Adenoma, Adnexal Diseases, +73 more
Locations: AO Riuniti Villa Sofia-Cervello di Palermo Palermo, Italy

University of Perugia Perugia, Italy

View Trial Details

Recruiting

Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)

NCT03760575

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Recruiting

The IMmunotherapy Pleural 5-ALA PDT

NCT04400539

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +13 more
Locations: Institut Coeur-Poumon, CHU Lille, France

View Trial Details